Correlation Between NYSE Composite and Cardio Diagnostics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Cardio Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Cardio Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Cardio Diagnostics Holdings, you can compare the effects of market volatilities on NYSE Composite and Cardio Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Cardio Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Cardio Diagnostics.
Diversification Opportunities for NYSE Composite and Cardio Diagnostics
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between NYSE and Cardio is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Cardio Diagnostics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardio Diagnostics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Cardio Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardio Diagnostics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Cardio Diagnostics go up and down completely randomly.
Pair Corralation between NYSE Composite and Cardio Diagnostics
Assuming the 90 days trading horizon NYSE Composite is expected to under-perform the Cardio Diagnostics. But the index apears to be less risky and, when comparing its historical volatility, NYSE Composite is 39.9 times less risky than Cardio Diagnostics. The index trades about -0.36 of its potential returns per unit of risk. The Cardio Diagnostics Holdings is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest 4.11 in Cardio Diagnostics Holdings on September 23, 2024 and sell it today you would earn a total of 5.68 from holding Cardio Diagnostics Holdings or generate 138.2% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
NYSE Composite vs. Cardio Diagnostics Holdings
Performance |
Timeline |
NYSE Composite and Cardio Diagnostics Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Cardio Diagnostics Holdings
Pair trading matchups for Cardio Diagnostics
Pair Trading with NYSE Composite and Cardio Diagnostics
The main advantage of trading using opposite NYSE Composite and Cardio Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Cardio Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardio Diagnostics will offset losses from the drop in Cardio Diagnostics' long position.NYSE Composite vs. BorgWarner | NYSE Composite vs. CarsalesCom Ltd ADR | NYSE Composite vs. Flexible Solutions International | NYSE Composite vs. Lucid Group |
Cardio Diagnostics vs. Fate Therapeutics | Cardio Diagnostics vs. Sana Biotechnology | Cardio Diagnostics vs. Caribou Biosciences | Cardio Diagnostics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Stocks Directory Find actively traded stocks across global markets |